Tessera Therapeutics
Founded Year
2018Stage
Series C | AliveTotal Raised
$530MLast Raised
$300M | 1 yr agoAbout Tessera Therapeutics
Tessera Therapeutics is an early-stage life science company pioneering Gene Writing, a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Tessera Therapeutics was founded in 2018 and is based in Cambridge, Massachusetts.
Missing: Tessera Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Tessera Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Tessera Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Tessera Therapeutics is included in 3 Expert Collections, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Unicorns- Billion Dollar Startups
1,215 items
Drug Discovery Tech Market Map
221 items
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
Latest Tessera Therapeutics News
May 19, 2023
RNA Gene Writing™ platform demonstrates continued advances in rewriting to correct pathogenic mutations responsible for... The post Tessera Therapeutics Presents New Data Demonstrating the Potential of Gene Writing™ Technology at the American Society of Gene and Cell Therapy 26th Annual Meeting first appeared on IT Business Net.
Tessera Therapeutics Frequently Asked Questions (FAQ)
When was Tessera Therapeutics founded?
Tessera Therapeutics was founded in 2018.
Where is Tessera Therapeutics's headquarters?
Tessera Therapeutics's headquarters is located at 55 Cambridge Parkway, Cambridge.
What is Tessera Therapeutics's latest funding round?
Tessera Therapeutics's latest funding round is Series C.
How much did Tessera Therapeutics raise?
Tessera Therapeutics raised a total of $530M.
Who are the investors of Tessera Therapeutics?
Investors of Tessera Therapeutics include Altitude Life Science Ventures, Alaska Permanent Fund, SoftBank , Longevity Vision Fund, T. Rowe Price and 11 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.